127.9, 135.2, 143.4, 147.3, 148.6, 174.6; m/z (ESI+) 470 ([M + H]+,
100%); HRMS (ESI+) found 470.2903; C43H56NO5Si ([M + H]+)
requires 470.2906.
174.9; m/z (ESI+) 694 ([M + H]+, 100%); HRMS (ESI+) found
694.3920; C43H56NO5Si ([M + H]+) requires 694.3928.
Acknowledgements
Parallel kinetic resolution of 21: tert-butyl (1R,2R,3R,aS)-2-
[N-benzyl-N-(a-methylbenzyl)amino]-3-tert-butyldiphenyl-
silyloxy-cyclopentane-carboxylate 35 and tert-butyl
(1S,2S,3S,aR)-2-[N-3,4-dimethoxybenzyl-N-(a-
methylbenzyl)amino]-3-tert-butyldiphenylsilyloxy-cyclopentane-
carboxylate 41
The authors would like to thank New College, Oxford for a Junior
Research Fellowship (A. D. S.).
References
1 S. C. Bergmeier, Tetrahedron, 2000, 56, 2561.
2 M. E. Bunnage, A. N. Chernega, S. G. Davies and C. J. Goodwin,
J. Chem. Soc., Perkin Trans. 1, 1994, 2373. For synthetic applications
of this transformation see: M. E. Bunnage, S. G. Davies and C. J.
Goodwin, Synlett, 1993, 731; M. E. Bunnage, S. G. Davies and C. J.
Goodwin, J. Chem. Soc., Perkin Trans. 1, 1993, 1375; M. E. Bunnage,
A. J. Burke, S. G. Davies and C. J. Goodwin, Tetrahedron: Asymmetry,
1994, 5, 203; M. E. Bunnage, S. G. Davies and C. J. Goodwin, J. Chem.
Soc., Perkin Trans. 1, 1994, 2385; M. E. Bunnage, A. J. Burke, S. G.
Davies and C. J. Goodwin, Tetrahedron: Asymmetry, 1995, 6, 165; A. J.
Burke, S. G. Davies and C. J. R. Hedgecock, Synlett, 1996, 621; M. E.
Bunnage, A. J. Burke, S. G. Davies, N. L. Millican, R. L. Nicholson,
P. M. Roberts and A. D. Smith, Org. Biomol. Chem., 2003, 1, 3708;
S. G. Davies, D. G. Hughes, R. L. Nicholson, A. D. Smith and A. J.
Wright, Org. Biomol. Chem., 2004, 2, 1549; E. Abraham, J. I. Candela-
Lena, S. G. Davies, M. Georgiou, R. L. Nicholson, P. M. Roberts, A. J.
Russell, E. M. Sa´nchez-Ferna´ndez, A. D. Smith and J. E. Thomson,
Tetrahedron: Asymmetry, 2007, 18, 2510.
3 (a) E. Abraham, J. W. B. Cooke, S. G. Davies, A. Naylor, R. L.
Nicholson, P. D. Price and A. D. Smith, Tetrahedron, 2007, 63, 5855;
(b) T. Cailleau, J. W. B. Cooke, S. G. Davies, K. B. Ling, A. Naylor,
R. L. Nicholson, P. D. Price, P. M. Roberts, A. J. Russell, A. D. Smith
and J. E. Thomson, Org. Biomol. Chem., 2007, 5, 3922.
4 For reviews see: S. Masamune, W. Choy, J. S. Petersen and L. R.
Sita, Angew. Chem., Int. Ed. Engl., 1985, 24, 1; O. I. Kolodiazhnyi,
Tetrahedron, 2003, 59, 5953.
5 (a) For kinetic resolution of 3-alkyl-cyclopent-1-ene-carboxylates see:
S. Bailey, S. G. Davies, A. D. Smith and J. M. Withey, Chem. Commun.,
2002, 2910; M. E. Bunnage, A. M. Chippindale, S. G. Davies, R. M.
Parkin Smith, A. D. Smith and J. M. Withey, Org. Biomol. Chem., 2003,
1, 3698; M. E. Bunnage, S. G. Davies, R. M. Parkin, P. M. Roberts, A. D.
Smith and J. M. Withey, Org. Biomol. Chem., 2004, 2, 3337; (b) For
parallel kinetic resolution of 3-alkyl-cyclopent-1-ene-carboxylates see:
S. G. Davies, A. C. Garner, M. J. C. Long, A. D. Smith, M. J. Sweet
and J. M. Withey, Org. Biomol. Chem., 2004, 2, 3355; (c) For kinetic
and parallel kinetic resolution of 5-alkyl-cyclopent-1-ene-carboxylates
see: S. G. Davies, D. D´ıez, M. M. El Hammouni, A. C. Garner, N. M.
Garrido, M. J. C. Long, R. M. Morrison, A. D. Smith, M. J. Sweet
and J. M. Withey, Chem. Commun., 2003, 2410; S. G. Davies, A. C.
Garner, M. J. C. Long, R. M. Morrison, P. M. Roberts, E. D. Savory,
A. D. Smith, M. J. Sweet and J. M. Withey, Org. Biomol. Chem., 2005,
3, 2762.
6 The high stereocontrol asserted upon protonation of an enolate anti to
an adjacent heteroatom is well documented, see: H. E. Zimmerman,
Acc. Chem. Res., 1987, 20, 263; J. E. Mohrig, R. E. Rosenberg, J. W.
Apostol, M. Bastienaansen, J. W. Evans, S. J. Franklin, C. D. Frisbie,
S. S. Fu, M. L. Hamm, C. B. Hirose, D. A. Hunstad, T. L. James, R. W.
King, C. J. Larson, H. A. Latham, D. A. Owen, K. A. Stein and R.
Warnet, J. Am. Chem. Soc., 1997, 119, 479; L. Banfi and G. Guanti,
Tetrahedron: Asymmetry, 1999, 10, 439; H. M. L. Davies, L. M. Hodges
and T. M. Gregg, J. Org. Chem., 2001, 66, 7898.
BuLi (2.5 M in hexanes, 469 lL, 1.17 mmol) was added
dropwise via syringe to a stirred solution of (S)-N-benzyl-
N-(a-methylbenzyl)amine (125 mg, 0.59 mmol), (R)-N-3,4-
dimethoxybenzyl-N-(a-methylbenzyl)amine (161 mg, 0.59 mmol)
in THF (16 mL) at −78 ◦C. After stirring for 30 min a solution of 21
(100 mg, 0.24 mmol) in THF (2 mL) at −78 ◦C was added dropwise
via a cannula. After stirring for a further 4 h at −78 ◦C the reaction
mixture was quenched with a solution of 2,6-di-tert-butylphenol in
THF and allowed to warm to rt over 1 h before being concentrated
in vacuo. The residue was partitioned between DCM (50 mL) and
10% aq. citric acid (10 mL). The organic layer was separated and
the aqueous layer was extracted with DCM (2 × 50 mL). The
combined organic extracts were washed sequentially with sat. aq.
NaHCO3 (50 mL) and brine (50 mL), dried and concentrated in
vacuo to give a 45 : 5 : 45 : 5 mixture of 35 : 36 : 41 : 42. Purification
by chromatography (1% Et2O in pentane) gave (1R,2R,3R,aS)-35
as a colourless oil (60 mg, 40%, >98% de); [a]2D4 −22.6 (c 1.0 in
=
CHCl3); mmax (film) 1722 (C O); dH (400 MHz, CDCl3) 1.09 (9H, s,
SiCMe3), 1.33–1.34 [1H, m, C(4)HA], 1.35 [3H, d, J 6.6, C(a)Me],
1.41 (9H, s, OCMe3), 1.52–1.28 [3H, m, C(4)HB, C(5)H2], 2.48–
2.49 [1H, m, C(1)H], 3.41 [1H, app t, J 7.7, C(2)H], 4.04–4.07 [3H,
m, C(a)H, NCH2], 4.65–4.70 [1H, m, C(3)H], 7.24–7.72 (20H, m,
Ph); dC (100 MHz, CDCl3) 16.5, 19.2, 25.0, 27.0, 28.1, 31.5, 47.3,
51.6, 57.2, 69.6, 76.0, 80.0, 126.4, 126.6, 127.4, 127.6, 128.0, 128.2,
128.3, 129.4, 129.5, 134.0, 134.9, 135.8, 135.9, 142.0, 144.1, 174.8;
m/z (ESI+) 634 ([M + H]+, 100%); HRMS (ESI+) found 634.3759;
C41H52NO3Si ([M + H]+) requires 634.3787. Further elution gave
(1S,2S,3S,aR)-41 as a colourless oil (59 mg, 36%, >98% de); [a]D24
=
+13.1 (c 1.0 in CHCl3); mmax (film) 1721 (C O); dH (400 MHz,
CDCl3) 1.07 (9H, s, SiCMe3), 1.21–1.47 [13H, m, C(4)HA, C(a)Me,
OCMe3], 1.52–1.60 [2H, m, C(5)H2], 1.61–1.68 [2H, m, C(4)HB],
2.46–2.49 [1H, m, C(1)H], 3.38–3.41 [1H, m, C(2)H], 3.86 (3H, s,
ArOMe), 3.88 (3H, s, ArOMe), 3.95 (2H, AB system, JAB 14.3,
NCH2), 4.05 [1H, q, J 6.7, C(a)H], 4.66–4.70 [1H, m, C(3)H],
6.76–7.71 (18H, m, Ar, Ph); dC (100 MHz, CDCl3) 15.5, 19.1,
24.8, 26.9, 28.0, 31.5, 47.7, 51.1, 55.5, 55.6, 56.4, 69.3, 75.9, 79.7,
110.6, 111.4, 119.9, 126.4, 129.4, 133.9, 135.8, 143.9, 147.5, 148.7,
7 The parent compound (1R,2S)-2-amino-cyclopentane-carboxylic acid
(cispentacin) has also attracted considerable synthetic attention; for
a review see: F. Fu¨lo¨p, Chem. Rev., 2001, 101, 2181. For recent
examples of the synthesis of cispentacin in enantioenriched form see:
V. K. Aggarwal, S. J. Roseblade, J. K. Barrell and R. Alexander,
Org. Lett., 2002, 4, 1227; C. Bohm, I. Schiffers, I. Atodiresi and
C. P. R. Hackenberger, Tetrahedron: Asymmetry, 2003, 14, 3455; V. K.
Aggarwal, S. J. Roseblade and R. Alexander, Org. Biomol. Chem., 2003,
1, 684.
2202 | Org. Biomol. Chem., 2008, 6, 2195–2203
This journal is
The Royal Society of Chemistry 2008
©